Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| OPKO HEALTH, INC.OPK · Entity 4891 | Director | June 18, 2026 | June 22, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
OPKO HEALTH, INC.
Report date June 18, 2026 · Filed June 22, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $1.42 · Expires 2036-06-17 | Direct | 80,000 |
Reported balance
After 2026-06-18 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2026-06-18 · Grant · Acquired 80,000 · Balance 80,000 F1: On June 18, 2026, the Issuer canceled the grant of 50,000 options previously made to the Reporting Person and, as a part of the Issuer's standard director compensation, granted the Reporting Person an option to purchase 30,000 shares, and reissued an option to purchase 50,000 shares of the Issuer's common stock. |
Filing footnotes · ownership attribution and instrument terms
F1: On June 18, 2026, the Issuer canceled the grant of 50,000 options previously made to the Reporting Person and, as a part of the Issuer's standard director compensation, granted the Reporting Person an option to purchase 30,000 shares, and reissued an option to purchase 50,000 shares of the Issuer's common stock.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| June 18, 2026 Filed Jun 22, 2026 21:33 UTC | OPKO HEALTH, INC. OPK · Entity 4891 | GrantStock Option (Right to Buy) · Derivative | 80,000 | $0.00 Strike: $1.42 | $0.00 |
DisclosureSEC source: 0001193125-26-277734 · ownership.xml · derivative · entry 1 UPPALURI SUBBARAO V · CIK 0001389406 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires 2036-06-17 F1 · kind: On June 18, 2026, the Issuer canceled the grant of 50,000 options previously made to the Reporting Person and, as a part of the Issuer's standard director compensation, granted the Reporting Person an option to purchase 30,000 shares, and reissued an option to purchase 50,000 shares of the Issuer's common stock. Read SEC document |
| March 18, 2026 Filed Mar 20, 2026 20:16 UTC | OPKO HEALTH, INC. OPK · Entity 4891 | GrantStock Option (Right to Buy) · Derivative | 50,000 | $0.00 Strike: $1.17 | $0.00 |
DisclosureSEC source: 0001193125-26-117673 · ownership.xml · derivative · entry 1 UPPALURI SUBBARAO V · CIK 0001389406 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 50,000 shares Expires 2036-03-17 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.